Joseph France
Stock Analyst at Cantor Fitzgerald
(2.66)
# 2,174
Out of 5,030 analysts
56
Total ratings
66.67%
Success rate
10.72%
Average return
Main Sectors:
Stocks Rated by Joseph France
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACHC Acadia Healthcare Company | Maintains: Neutral | $83 → $85 | $24.17 | +251.75% | 7 | Sep 14, 2023 | |
HCA HCA Healthcare | Maintains: Buy | $285 → $320 | $426.16 | -24.91% | 3 | Apr 24, 2023 | |
ELV Elevance Health | Maintains: Buy | $565 → $550 | $348.77 | +57.70% | 1 | Apr 21, 2023 | |
UNH UnitedHealth Group | Maintains: Buy | $590 → $600 | $356.60 | +68.26% | 4 | Apr 17, 2023 | |
CCRN Cross Country Healthcare | Initiates: Buy | $30 | $12.63 | +137.53% | 9 | Mar 10, 2023 | |
CVS CVS Health | Initiates: Buy | $120 | $82.52 | +45.42% | 2 | Jun 17, 2022 | |
THC Tenet Healthcare | Initiates: Buy | $80 | $200.00 | -60.00% | 2 | Jun 17, 2022 | |
UHS Universal Health Services | Initiates: Hold | $115 | $204.56 | -43.78% | 3 | Jun 17, 2022 | |
CI The Cigna Group | Initiates: Hold | $270 | $299.27 | -9.78% | 2 | Jun 17, 2022 | |
MOH Molina Healthcare | Initiates: Hold | $310 | $192.68 | +60.89% | 1 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5 | $3.08 | +62.34% | 2 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $510 | $275.01 | +85.45% | 3 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $35.27 | +183.53% | 2 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $50 | $182.04 | -72.53% | 3 | Nov 2, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $103 → $107 | $88.93 | +20.32% | 3 | Nov 2, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $10 | $2.22 | +350.45% | 2 | Sep 28, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $118.30 | -34.91% | 1 | Sep 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $46 | $35.22 | +30.61% | 1 | Aug 10, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $80 | $75.35 | +6.17% | 1 | Aug 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $34 | $41.06 | -17.19% | 1 | Dec 21, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $21 | $18.55 | +13.21% | 1 | Nov 7, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $60 | $31.95 | +87.79% | 1 | Sep 1, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $7 | $26.52 | -73.60% | 1 | Jul 6, 2017 |
Acadia Healthcare Company
Sep 14, 2023
Maintains: Neutral
Price Target: $83 → $85
Current: $24.17
Upside: +251.75%
HCA Healthcare
Apr 24, 2023
Maintains: Buy
Price Target: $285 → $320
Current: $426.16
Upside: -24.91%
Elevance Health
Apr 21, 2023
Maintains: Buy
Price Target: $565 → $550
Current: $348.77
Upside: +57.70%
UnitedHealth Group
Apr 17, 2023
Maintains: Buy
Price Target: $590 → $600
Current: $356.60
Upside: +68.26%
Cross Country Healthcare
Mar 10, 2023
Initiates: Buy
Price Target: $30
Current: $12.63
Upside: +137.53%
CVS Health
Jun 17, 2022
Initiates: Buy
Price Target: $120
Current: $82.52
Upside: +45.42%
Tenet Healthcare
Jun 17, 2022
Initiates: Buy
Price Target: $80
Current: $200.00
Upside: -60.00%
Universal Health Services
Jun 17, 2022
Initiates: Hold
Price Target: $115
Current: $204.56
Upside: -43.78%
The Cigna Group
Jun 17, 2022
Initiates: Hold
Price Target: $270
Current: $299.27
Upside: -9.78%
Molina Healthcare
Jun 17, 2022
Initiates: Hold
Price Target: $310
Current: $192.68
Upside: +60.89%
Jun 17, 2022
Initiates: Hold
Price Target: $5
Current: $3.08
Upside: +62.34%
Jun 17, 2022
Initiates: Buy
Price Target: $510
Current: $275.01
Upside: +85.45%
Jun 17, 2022
Initiates: Buy
Price Target: $100
Current: $35.27
Upside: +183.53%
Nov 2, 2018
Maintains: Overweight
Price Target: $42 → $50
Current: $182.04
Upside: -72.53%
Nov 2, 2018
Maintains: Neutral
Price Target: $103 → $107
Current: $88.93
Upside: +20.32%
Sep 28, 2018
Downgrades: Neutral
Price Target: $12 → $10
Current: $2.22
Upside: +350.45%
Sep 13, 2018
Initiates: Overweight
Price Target: $77
Current: $118.30
Upside: -34.91%
Aug 10, 2018
Maintains: Overweight
Price Target: $45 → $46
Current: $35.22
Upside: +30.61%
Aug 8, 2018
Maintains: Neutral
Price Target: $75 → $80
Current: $75.35
Upside: +6.17%
Dec 21, 2017
Initiates: Overweight
Price Target: $34
Current: $41.06
Upside: -17.19%
Nov 7, 2017
Maintains: Overweight
Price Target: $20 → $21
Current: $18.55
Upside: +13.21%
Sep 1, 2017
Initiates: Overweight
Price Target: $60
Current: $31.95
Upside: +87.79%
Jul 6, 2017
Initiates: Overweight
Price Target: $7
Current: $26.52
Upside: -73.60%